This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Oct;139(10):1369-70; author reply 1370-1.

doi: 10.1001/archderm.139.10.1369.

1% pimecrolimus cream for atopic dermatitis

Lawrence F Eichenfield, Anne W Lucky, Mark Boguniewicz, Richard G B Langley, Robert Cherill, Katharine Marshall

PMID: 14568846
DOI: 10.1001/archderm.139.10.1369

Comment

1% pimecrolimus cream for atopic dermatitis

Lawrence F Eichenfield et al. Arch Dermatol. 2003 Oct.

. 2003 Oct;139(10):1369-70; author reply 1370-1.

doi: 10.1001/archderm.139.10.1369.

Authors

Lawrence F Eichenfield, Anne W Lucky, Mark Boguniewicz, Richard G B Langley, Robert Cherill, Katharine Marshall

PMID: 14568846
DOI: 10.1001/archderm.139.10.1369

No abstract available

PubMed Disclaimer

Comment on

Another vehicle-controlled study of 1% pimecrolimus in atopic dermatitis: how does it help clinicians and patients, and is it ethically sound?
Williams H. Williams H. Arch Dermatol. 2002 Dec;138(12):1602-3. doi: 10.1001/archderm.138.12.1602. Arch Dermatol. 2002. PMID: 12472351 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- ClinicalTrials.gov